Ratings by Piper Sandler (Christopher Raymond)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/20/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
9/15/2021 Regeneron Pharma REGN Maintain Overweight
(N/A)
 
 
  Details
8/25/2021 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
8/23/2021 Nuvalent NUVL New Coverage Overweight
(N/A)
26.40
(22.86)
-13.41% Details
7/29/2021 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
7/20/2021 Ardelyx, Inc ARDX Downgrade Neutral
(Overweight)
7.50
(1.31)
-82.53% Details
7/12/2021 Solid Biosciences SLDB New Coverage Neutral
(N/A)
3.45
(2.67)
-22.61% Details
6/18/2021 Biogen BIIB Upgrade Overweight
(Neutral)
391.31
(291.71)
-25.45% Details
6/15/2021 Aclaris Therapeutis ACRS New Coverage Overweight
(N/A)
17.83
(18.07)
1.35% Details
6/7/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
5/11/2021 Inovio Pharmaceuticals INO Maintain Neutral
(N/A)
 
 
  Details
5/11/2021 Akebia Therapeutics AKBA Maintain Overweight
(N/A)
 
 
  Details
5/4/2021 Kinnate Biopharma KNTE New Coverage Overweight
(N/A)
26.82
(22.67)
-15.47% Details
4/28/2021 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
4/19/2021 Oncorus Inc. ONCR Maintain Overweight
(N/A)
 
 
  Details
4/13/2021 Otonomy OTIC New Coverage Overweight
(N/A)
2.22
(1.76)
-20.72% Details
3/23/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
3/2/2021 Inovio Pharmaceuticals INO Maintain Neutral
(N/A)
 
 
  Details
2/12/2021 Ultragenyx Pharma RARE Maintain Overweight
(N/A)
 
 
  Details
2/4/2021 Alexion Pharmaceuticals ALXN Downgrade Neutral
(Overweight)
154.74
(182.01)
17.62% Details
2/4/2021 Deciphera DCPH Maintain Overweight
(N/A)
 
 
  Details
1/21/2021 Ardelyx, Inc ARDX Maintain Overweight
(N/A)
 
 
  Details
12/15/2020 Abbvie ABBV Maintain Overweight
(Overweight)
 
 
  Details
10/27/2020 Aptinyx APTX New Coverage Overweight
(N/A)
3.13
(2.39)
-23.64% Details
10/27/2020 Oncorus Inc. ONCR New Coverage Overweight
(N/A)
15.51
(9.47)
-38.94% Details
10/20/2020 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
10/6/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
8/31/2020 Aimmune Therapeutics AIMT Downgrade Neutral
(Overweight)
12.60
(34.49)
173.73% Details
8/18/2020 iTeos Therapeutics ITOS New Coverage Overweight
(N/A)
31.40
(27.46)
-12.55% Details
7/29/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
7/22/2020 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
6/19/2020 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
4/9/2020 Prevail Therapeutics PRVL New Coverage Overweight
(N/A)
12.36
(23.00)
86.08% Details
3/13/2020 Inovio Pharmaceuticals INO Downgrade Neutral
(Overweight)
8.37
(7.76)
-7.29% Details
2/25/2020 Regeneron Pharma REGN Maintain Overweight
(N/A)
 
 
  Details
2/7/2020 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
1/29/2020 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
1/29/2020 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
1/10/2020 AMAG Pharmaceuticals AMAg Maintain Neutral
(N/A)
 
 
  Details
1/3/2020 Inovio Pharmaceuticals INO Maintain Overweight
(N/A)
 
 
  Details
1/2/2020 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
12/3/2019 Audentes Therapeutics BOLD Downgrade Neutral
(Overweight)
29.03
(59.97)
106.58% Details
11/12/2019 Akebia Therapeutics AKBA Maintain Overweight
(N/A)
 
 
  Details
11/12/2019 Rockwell Medical Technologies RMTI Maintain Overweight
(N/A)
 
 
  Details
10/30/2019 AMAG Pharmaceuticals AMAG Downgrade Underweight
(Neutral)
13.33
(9.40)
-29.48% Details
10/17/2019 Ardelyx, Inc ARDX Maintain Overweight
(N/A)
 
 
  Details
10/9/2019 Aimmune Therapeutics AIMT Maintain Overweight
(N/A)
 
 
  Details
10/1/2019 Aimmune Therapeutics AIMT Maintain Overweight
(N/A)
 
 
  Details
9/13/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
9/11/2019 Aimmune Therapeutics AIMT Maintain Overweight
(N/A)
 
 
  Details
9/4/2019 Abbvie ABBV Maintain Overweight
(N/A)
 
 
  Details
8/29/2019 Blueprint Medicines BPMC New Coverage Neutral
(N/A)
77.72
(106.61)
37.17% Details
8/26/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
8/22/2019 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
8/20/2019 Abbvie ABBV Upgrade Overweight
(Neutral)
66.56
(107.07)
60.86% Details
7/24/2019 Regeneron Pharma REGN Maintain Overweight
(N/A)
 
 
  Details
7/18/2019 Akebia Therapeutics AKBA Maintain Overweight
(N/A)
 
 
  Details
6/28/2019 Biogen BIIB Downgrade Neutral
(Overweight)
238.07
(291.71)
22.53% Details
6/26/2019 Abbvie ABBV Maintain Neutral
(Neutral)
 
 
  Details
6/24/2019 Rockwell Medical Technologies RMTI New Coverage Overweight
(N/A)
3.02
(0.65)
-78.48% Details
6/3/2019 Deciphera DCPH Maintain Overweight
(N/A)
 
 
  Details
5/8/2019 Regeneron Pharma REGN Maintain Overweight
(N/A)
 
 
  Details
4/8/2019 Audentes Therapeutics BOLD Maintain Overweight
(N/A)
 
 
  Details
4/8/2019 Ardelyx, Inc ARDX New Coverage Overweight
(N/A)
3.07
(1.31)
-57.33% Details
3/21/2019 Biogen BIIB Maintain Overweight
(N/A)
 
 
  Details
3/14/2019 Sophiris Bio SPHS Maintain Overweight
(N/A)
 
 
  Details
2/28/2019 Audentes Therapeutics BOLD Maintain Overweight
(N/A)
 
 
  Details
1/30/2019 Amgen AMGN Maintain Neutral
(N/A)
 
 
  Details
11/7/2018 Audentes Therapeutics BOLD Maintain Overweight
(N/A)
 
 
  Details
11/1/2018 AMAG Pharmaceuticals AMAG Maintain Neutral
(N/A)
 
 
  Details
10/29/2018 Amgen AMGN Maintain Overweight
(N/A)
 
 
  Details
10/26/2018 Ultragenyx Pharma RARE Maintain Overweight
(N/A)
 
 
  Details
10/2/2018 Abbvie ABBV Maintain Neutral
(N/A)
 
 
  Details
9/26/2018 Inovio Pharmaceuticals INO Maintain Overweight
(Overweight)
 
 
  Details
9/17/2018 Tesaro TSRO Maintain Neutral
(Neutral)
 
 
  Details
9/4/2018 Deciphera DCPH Maintain Overweight
(N/A)
 
 
  Details
8/29/2018 Ultragenyx Pharma RARE Maintain Overweight
(N/A)
 
 
  Details
8/17/2018 Regeneron Pharma REGN Maintain Overweight
(Overweight)
 
 
  Details